Candel Therapeutics Statistics

Total Valuation

CADL has a market cap or net worth of $178.83 million. The enterprise value is $173.94 million.

Market Cap	178.83M
Enterprise Value	173.94M

Important Dates

The next estimated earnings date is Thursday, August 8, 2024, before market open.

Earnings Date	Aug 8, 2024
Ex-Dividend Date	n/a

Share Statistics

CADL has 29.76 million shares outstanding. The number of shares has increased by 0.96% in one year.

Shares Outstanding	29.76M
Shares Change (YoY)	+0.96%
Shares Change (QoQ)	+0.74%
Owned by Insiders (%)	33.51%
Owned by Institutions (%)	13.47%
Float	18.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	29.91
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.01, with a Debt / Equity ratio of 3.53.

Current Ratio	2.01
Quick Ratio	n/a
Debt / Equity	3.53
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-13.20

Financial Efficiency

Return on equity (ROE) is -206.10% and return on invested capital (ROIC) is -135.46%.

Return on Equity (ROE)	-206.10%
Return on Assets (ROA)	-82.50%
Return on Capital (ROIC)	-135.46%
Revenue Per Employee	n/a
Profits Per Employee	-$889,643
Employee Count	42
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +384.68% in the last 52 weeks. The beta is -0.94, so CADL's price volatility has been lower than the market average.

Beta (5Y)	-0.94
52-Week Price Change	+384.68%
50-Day Moving Average	7.92
200-Day Moving Average	3.55
Relative Strength Index (RSI)	43.29
Average Volume (20 Days)	604,687

Short Selling Information

The latest short interest is 1.01 million, so 3.39% of the outstanding shares have been sold short.

Short Interest	1.01M
Short Previous Month	1.06M
Short % of Shares Out	3.39%
Short % of Float	5.55%
Short Ratio (days to cover)	1.39

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-36.66M
Pretax Income	-37.37M
Net Income	-37.37M
EBITDA	-33.50M
EBIT	-34.73M
Earnings Per Share (EPS)	-$1.28

Full Income Statement

Balance Sheet

The company has $25.98 million in cash and $21.09 million in debt, giving a net cash position of $4.89 million or $0.16 per share.

Cash & Cash Equivalents	25.98M
Total Debt	21.09M
Net Cash	4.89M
Net Cash Per Share	$0.16
Equity (Book Value)	5.98M
Book Value Per Share	0.20
Working Capital	13.60M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$31.86 million and capital expenditures -$306,000, giving a free cash flow of -$32.17 million.

Operating Cash Flow	-31.86M
Capital Expenditures	-306,000
Free Cash Flow	-32.17M
FCF Per Share	-$1.10

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CADL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.96%
Shareholder Yield	-0.96%
Earnings Yield	-20.89%
FCF Yield	-17.99%

Analyst Forecast

The average price target for CADL is $11.00, which is 83.03% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.00
Price Target Difference	83.03%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2